Halozyme Therapeutics shares owned by Waddell & Reed Financial
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Waddell & Reed Financial
from 13F filings
Historical chart of Waddell & Reed Financial investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Waddell & Reed Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Waddell & Reed Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2021-03-31 | $20M | 477k | 41.69 |
| 2020-12-31 | $42M | 993k | 42.71 |
| 2020-09-30 | $35M | 1.3M | 26.28 |
| 2020-06-30 | $28M | 1.1M | 26.81 |